The following represents disclosure information provided by authors of this abstract. ASCO's Quality Care Symposium Planning Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pathways impact on chemotherapy administration before death.
Marcus A. Neubauer
Employment or Leadership Position - McKesson
Jody S. Garey
Employment or Leadership Position - McKesson Specialty Health
Brian Turnwald
No relevant relationships to disclose
Josh Howell
No relevant relationships to disclose
Robyn K. Harrell
No relevant relationships to disclose
Jad Hayes
No relevant relationships to disclose
Debajyoti Bhowmik
No relevant relationships to disclose
J. Russell Hoverman
No relevant relationships to disclose
Barry Don Brooks
Employment or Leadership Position - The US Oncology Network